Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARAMEL
2024-517751-13-01Phase 2Completed
- Sponsor
- Centre Hospitalier Le Vinatier
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Cannabidiol with Placebo cannabidiol (2 arms). Primary endpoint: Change in total alcohol consumption over last 28 days of study. Started Nov 2024; status: completed.
02
Drugs
cannabidiol
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on 2024-517751-13-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517751-13-01.